News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Earnings (World)
SQI Diagnostics Reports Fourth Quarter And Fiscal 2016 Results 12/7/2016
GW Pharma (GWPH) Reports Fourth Quarter And Year-End 2016 Financial Results And Operational Progress 12/5/2016
Ascendis Reports Third Quarter 2016 Financial Results 12/1/2016
GW Pharma (GWPH) To Report Q4 And Year-End Financial Results And Host Conference Call On 5 December, 2016 12/1/2016
Antibe Therapeutics (ATE.V) Reports Q2 2017 Interim Financial And Operating Results 11/30/2016
Mallinckrodt (MNK) Reports Fiscal 2016 Fourth Quarter And Full-Year Results 11/29/2016
Advanced Accelerator Applications Reports 15.4% Sales Growth In The Third Quarter Of 2016 And Feedback From The FDA For Lutathera, An Investigational Treatment For Neuroendocrine Tumors 11/28/2016
BiondVax Pharmaceuticals Announces Third Quarter 2016 Financial Results And Update 11/28/2016
Can-Fite BioPharma (CFBI) Reports Financial Results For Nine Months Ended September 30, 2016 & Provides Clinical Update 11/28/2016
Sinovac Biotech Ltd. (SVA) Reports Unaudited Third Quarter 2016 Financial Results 11/28/2016
Wilson Therapeutics Interim Report January 1 – September 30, 2016 11/28/2016
Advanced Accelerator Applications To Announce Third Quarter And Nine-Month 2016 Financial Results On November 28 11/23/2016
Karolinska Development AB: Interim Report For January-September 2016 11/23/2016
Nordic Nanovector– Results For Third Quarter 2016 11/23/2016
Golden Meditech Announces FY2016/2017 Interim Results 11/23/2016
Biostar Pharmaceuticals, Inc. (BSPM) Announces Its Quarterly Results for Three Months Ended September 30, 2016 11/22/2016
BioLineRx Reports Third Quarter 2016 Financial Results 11/22/2016
Innocoll (INNL) Announces Third Quarter 2016 Financial And Operating Results And Provides Corporate Update 11/22/2016
NeuroVive (NVP) Interim Report January - September 2016 11/22/2016
Oxford Gene Technology Ltd. Announces Commercial and Financial Highlights For FY 2016 11/22/2016
China Cord Blood Reports Financial Results For The Second Quarter And First Half Of Fiscal 2017 11/18/2016
Tikcro Technologies Reports Third Quarter 2016 Results 11/18/2016
Karolinska Development AB – Q3 2016 Interim Report - Invitation To Conference Call And Webcast 11/17/2016
Nabriva Reports Third Quarter 2016 Financial Results 11/16/2016
Alcobra (ADHD) Announces Third Quarter 2016 Financial Results And Provides Corporate Update 11/15/2016
BrainStorm Cell Reports Third Quarter 2016 Financial Results 11/15/2016
BioLineRx To Report Third Quarter Results On November 22, 2016 11/15/2016
China Pharma Holdings (CPHI.OB) Reports Third Quarter Financial Results 11/15/2016
Innocoll (INNL) To Report Third Quarter 2016 Financial Results And Host Webcast And Conference Call On November 22, 2016 11/15/2016
ProMetic Life Sci (PFSCF.PK) Reports Third Quarter 2016 Highlights And Financial Results 11/15/2016
Sinovac Biotech Ltd. (SVA) To Host Conference Call To Report Third Quarter 2016 Unaudited Financial Results 11/15/2016
Teva (TEVA) Reports Third Quarter 2016 Results 11/15/2016
Neovasc (NVC) Reports Third Quarter Results For 2016 11/15/2016
OncoGenex (OGXI) Reports Financial Results For Third Quarter 2016 11/14/2016
SciBase AB: Interim Report 11/14/2016
Perrigo (PRGO) Reports Third Quarter 2016 Financial Results 11/11/2016
Medicure (MCU) Reports Third Quarter 2016 Financial Results 11/11/2016
Adaptimmune (ADAP) Reports Third Quarter 2016 Financial Results 11/10/2016
Biotage AB (BIOTa.ST): Interim Report January-September 2016 11/10/2016
Bactiguard AB: Interim Report For Q3 2016 11/10/2016
Evotec AG (EVTG.F) Reports Results Of First Nine Months Of 2016 11/10/2016
Mylan (MYL) Reports Third Quarter 2016 Results 11/10/2016
NeuroDerm (NDRM) Announces Third Quarter 2016 Financial Results 11/10/2016
Recipharm AB Release: Interim Report January-September 2016 11/10/2016
Axovant (AXON) Announces Dementia Pipeline Updates And Reports Financial Results For The Second Fiscal Quarter And First Half Ended September 30, 2016 11/9/2016
Epigenomics AG Announces 2016 Third Quarter And Nine Months Financial Results And Reports On Operational Highlights 11/9/2016
Endo International (ENDP) Reports Third Quarter 2016 Financial Results 11/9/2016
Jazz Pharma (JAZZ) Announces Third Quarter 2016 Financial Results 11/9/2016
Hansa Medical Interim Report July – September 2016 11/9/2016
Bone Therapeutics Taps a New CEO, Drops Plan to Initiate Cell Therapy Trial in the U.S. 11/8/2016
GENFIT (ALGFT): Third Quarter 2016 Financial Information 11/8/2016
Galmed Pharmaceuticals Reports Third Quarter 2016 Financial Results And Provides Business Update 11/8/2016
Compugen Ltd. (CGEN) Reports 3rd Quarter 2016 Financial Results 11/7/2016
Flamel Technologies (FLML) Reports Third Quarter 2016 Results 11/7/2016
Horizon Pharma (HZNP) Announces Third-Quarter 2016 Financial Results 11/7/2016
Merus (MRUS) Announces Third Quarter 2016 Financial Results And Corporate Developments 11/7/2016
Auris Med (EARS) To Announce Third Quarter 2016 Financial Results And Host Conference Call On Thursday, November 10, 2016 11/4/2016
BioAmber Reports Third Quarter 2016 Financial And Operational Results 11/4/2016
ERYtech Pharma Provides Business Update And Reports Financial Highlights For Third Quarter 2016 11/4/2016
Nexvet Reports Financial Results For First Quarter Of Fiscal Year 2017 11/4/2016
N1 Technologies Posts Strong 3Q Results 11/4/2016
China Biologic Products Reports Financial Results For The Third Quarter Of 2016 11/3/2016
Evotec AG (EVTG.F) To Report First Nine-Month 2016 Results On 10 November 2016 11/3/2016
Genmab A/S (GEN.CO) Announces Financial Results For The First Nine Months Of 2016 And Improves 2016 Financial Guidance 11/3/2016
Kamada Ltd. (KMDA) To Host Third Quarter Financial Results Conference Call On November 10, 2016 At 8:30 Am Eastern Time 11/3/2016
QIAGEN N.V. (QGEN) Reports Results For Third Quarter And First Nine Months Of 2016 11/3/2016
In 3Q Report, Shire (SHPG) Breaks Out Data From Baxalta (BXLT) Acquisition and Announces Several Program Terminations 11/2/2016
Acerus (TRLPF) Reports Third Quarter 2016 Financial Results 11/2/2016
Alkermes (ALKS) Reports Third Quarter 2016 Financial Results 11/2/2016
Bone Therapeutics Notice Of Q3 2016 Results 11/2/2016
Theravance (THRX) To Report Third Quarter 2016 Financial Results On November 8, 2016 11/2/2016
Mauna Kea Technologies Reports Third Quarter 2016 Sales 11/2/2016
Alcobra (ADHD) To Release Third Quarter Financial Results And Host Corporate Update Conference Call & Webcast On November 15 11/1/2016
Cardiome Pharma Corp. (COM.TO) To Reschedule Release Of Third Quarter 2016 Financial Results 11/1/2016
Helix Biopharma (TSX:HBP) Announces Fiscal 2016 Results 11/1/2016
MMJ PhytoTech Quarterly Update And Appendix 4C 11/1/2016
NeuroDerm (NDRM) To Host Third Quarter 2016 Financial Results Conference Call On November 10, 2016 11/1/2016
Oxford Immunotec (OXFD) Reports Third Quarter 2016 Financial Results 11/1/2016
Quotient Limited (QTNTU) Reports Continued Progress On The Commercial Scale-Up Of Mosaiq™ And Second Quarter Fiscal 2017 Financial Results 11/1/2016
NOXXON Pharma AG Releases Its Interim 2016 Results 10/31/2016
Galapagos (GLPG.BR) Release: Robust Progress In Q3 2016 10/28/2016
Sanofi (SNY) Announces Strong Q3 2016 Results 10/28/2016
Takeda (TKPYY) Reports First Half FY2016 Results And Raises Full Year Profit Guidance 10/28/2016
Alkermes (ALKS) To Host Conference Call To Discuss Third Quarter 2016 Financial Results 10/27/2016
Concordia (CXR.TO) Announces Release Date For Third Quarter 2016 Results 10/27/2016
Hanmi Pharma (128940.KS)’s Q3 Operating Profit Plunges 62% 10/27/2016
Karo Pharma: Interim Report January – September 2016 10/27/2016
Lonza Group (LZAGY.PK) Expects To Reach 2018 Guidance One Year Ahead And Reports Strong Q3 Momentum 10/27/2016
Swedish Orphan Biovitrum AB: Sobi Publishes Its Report For The Third Quarter 2016, Raises Guidance 10/27/2016
Flamel Technologies (FLML) To Report Third Quarter 2016 Results 10/26/2016
Jazz Pharma (JAZZ) To Report 2016 Third Quarter Financial Results On November 8, 2016 10/26/2016
Turning Around Novartis AG (NVS)'s Struggling Alcon (ACL) Unit Will Take Longer Than Expected 10/26/2016
BioAmber Announces Webcast Of Fiscal Third Quarter 2016 Financial Results 10/25/2016
China Biologic Products To Report Third Quarter 2016 Financial Results 10/25/2016
Dr. Reddy's Laboratories Ltd. (RDY)’s Q2 And H1 FY17 Financial Results 10/25/2016
ICON Reports Third Quarter 2016 Results 10/20/2016
Orexo (ORXOF): Interim Report January-September 2016 10/20/2016
TRANSGENE (ENX:TNG) Reports Third Quarter 2016 Financial Results 10/20/2016
ThromboGenics NV (TBGNF) Business Update – Q3 2016 10/20/2016
Microbix Biosystems Inc. (MBXBF) Announces Preliminary Sales For 2016 10/19/2016
Endo International (ENDP) To Announce Third Quarter 2016 Financial Results On November 8, 2016 10/18/2016
Valeant (VRX) Announces Third Quarter Financial Results Date And Conference Call Details 10/18/2016
Quotient Limited (QTNTU) To Report Second Quarter Fiscal 2017 Financial Results And Host Conference Call 10/17/2016
Allergan (AGN) To Host Third Quarter 2016 Earnings Conference Call And Webcast 10/14/2016
Dr. Reddy's Laboratories Ltd. (RDY)'s To Release Q2 FY17 Results On Oct 25, 2016; Earnings Call Slated For Oct 25, 6.30 PM IST / 9.00 AM EDT 10/14/2016
Adocia Announces Third Quarter 2016 Financial Results 10/13/2016
Vexim Release: +37% Sales Increase To €13.3 Million As Of September 30, 2016 (9 Months) New Quarterly Sales Record 10/13/2016
Figures And Highlights 2015: Ascenion GmbH's Annual Report 10/12/2016
Compugen Ltd. (CGEN) Third Quarter Financial Statements To Be Released November 7, 2016 10/10/2016
MEDICREA Announces 2016 Third-Quarter Sales 10/7/2016
Veritas Pharma Inc Release: Cannevert Delivers Its Quarterly Research Report 10/6/2016
Neovacs Release: Half-Year Results 2016 And Update On Operational Development 10/3/2016
Pharming Group (PHGUF.PK) Reports On Financial Results For The First Eight Months Of 2016 10/3/2016
Addex Therapeutics (ADXN.SW) Reports First Half 2016 Operating Highlights And Financial Results 9/30/2016
BioCorp Release: 2016 Half-Year Results: Development In Keeping With The Strategy, Confirming The Objectives Set 9/29/2016
Tiziana Life Sciences Plc Announces Interim Results For The Six Months Ended 30 June 2016 9/29/2016
Vernalis PLC (VNLPY.PK) Announces Results Announcement For The 12 Months Ended 30 June 2016 9/29/2016
Clinigen Release: Transformational Year Delivers 25% Growth In Adjusted EPS 9/28/2016
Seventure Partners Life Sciences Update For May - September 2016 9/28/2016
Silence Therapeutics Release: Interim Results For The Six Months Ended 30 June 2016 9/27/2016
XTL Biopharma (XTLB) Reports Second Quarter 2016 Financial Results & Provides Clinical And Operational Update 9/27/2016
MEDICREA Announces Results For The 1st Half Of 2016 9/23/2016
Mauna Kea Technologies Reports 1H 2016 Financial Results 9/23/2016
e-Therapeutics Release: Re-Focused, Science Based And Commercially Driven With £19.9 Million Of Cash 9/20/2016
Newron Pharma (NWRN) Reports Half-Year 2016 Results 9/15/2016
MagForce AG To Present Its NanoTherm Therapy For The Treatment Of Brain Tumors At 36th ESSO Congress In Poland 9/8/2016
EOS Imaging Reports First-Half 2016 Results 9/8/2016
Dechra Pharmaceuticals PLC: Annual Results 9/6/2016
ERYtech Pharma Reports Business And Financial Update For The First Half Of 2016 9/6/2016
Sectra (SECTB)’s Three-Month Interim Report 2016/2017: Multiyear Managed-Services Agreements Contribute To Sectra’s Positive Performance 9/6/2016
TRANSGENE (ENX:TNG) Provides An Update On Its Development Strategy And On Its First Half-Year 2016 Financials 9/6/2016
Midatech: Interim Results For The Six Months Ended 30 June 2016 9/2/2016
Nexvet Reports Full Year Fiscal 2016 Results 9/2/2016
Vexim: Amendment Of The Financial Agenda For 2016 9/2/2016
Intec Pharma Reports First Half 2016 Financial Results 9/1/2016
Elekta: Interim Report May – July 2016/17 9/1/2016
Novartis AG (NVS)'s Vaccines Pain Becomes GlaxoSmithKline (GSK)'s Gain 8/31/2016
Advanced Accelerator Applications Reports 24.4% Sales Growth In The Second Quarter Of 2016 8/31/2016
Karolinska Development AB: Interim Report For January-June 2016 8/31/2016
Alcobra (ADHD) Announces Second Quarter 2016 Financial Results And Provides Corporate Update 8/30/2016
Anatara Lifesciences Appendix 4E And Financial Report 8/30/2016
ERYtech Pharma To Hold Q2 2016 Business Update Conference Call On September 7th, 2016 8/30/2016
Unilabs SA Delivers 8th Consecutive Quarter Of Organic Sales And EBITDA Growth 8/30/2016
Bone Therapeutics Announces H1 Results For 2016 8/30/2016
Karolinska Development AB – Q2 2016 Interim Report - Invitation To Conference Call And Webcast 8/29/2016
Osprey Med Release: Half Yearly Accounts Report 8/29/2016
Can-Fite BioPharma (CFBI) Reports Financial Results For Six Months Ended June 30, 2016 8/26/2016
Concord Medical Services Holdings Limited (CCM) Reports Financial Results For The First Half Of 2016 8/25/2016
NeuroDerm (NDRM) Announces Second Quarter 2016 Financial Results And Provides Corporate Update 8/25/2016
Cantargia Interim Report January – June 2016 8/24/2016
Nordic Nanovector — Results For Second Quarter And Half Year 2016 8/24/2016
Regeneus (RGS.AX) FY16 Results Presentation 8/24/2016
Regeneus (RGS.AX) FY16 Results Announcement 8/24/2016
Medtronic (MDT) Earnings Face FX Headwinds, But Cardiac Trends Good 8/24/2016
Biostar Pharmaceuticals, Inc. (BSPM) Announces Its Quarterly Results For Three Months Ended June 30, 2016 8/23/2016
China Cord Blood Reports Financial Results For The First Quarter Of Fiscal 2017 8/23/2016
Probiodrug AG To Publish First Half 2016 Results On 30 August 2016 8/23/2016
Sinovac Biotech Ltd. (SVA) Reports Unaudited Second Quarter 2016 Financial Results 8/23/2016
Ascendis Pharma A/S To Report Second Quarter 2016 Financial Results And Host Conference Call On August 31 8/19/2016
BiondVax Pharmaceuticals Announces Second Quarter 2016 Financial Results And Update 8/19/2016
SciBase AB: Interim Report 8/19/2016
Covalon Technologies Ltd. Announces Conference Call To Discuss Third Quarter Financial Results 8/19/2016
Wilson Therapeutics Interim Report January 1 – June 30, 2016 8/18/2016
Innocoll (INNL) Announces Second Quarter 2016 Financial And Operating Results And Provides Corporate Update 8/17/2016
Kitov (KTOV) Issues First Half 2016 Financial Reports 8/17/2016
ProQR Therapeutics B.V. (PRQR) Announces Results For The Second Quarter Of 2016 8/17/2016
Auris Medical AG (EARS) To Announce Second Quarter 2016 Financial Results And Host Conference Call And Webcast On Thursday, August 18, 2016 8/16/2016
Axovant (AXON) Announces Expansion Of Dementia Pipeline And Reports Financial Results For The First Fiscal Quarter Ended June 30, 2016 8/16/2016
China Cord Blood To Report First Quarter Of Fiscal 2017 Financial Results 8/16/2016
Sinovac Biotech Ltd. (SVA) To Host Conference Call To Report Second Quarter And 2016 Unaudited Financial Results 8/15/2016
Merus Labs International Inc.  (MSLI) Reports Fiscal Q3 2016 Results 8/15/2016
Targovax: Invitation To Second Quarter 2016 Results Presentation Thursday 25 August 8/15/2016
VBL Therapeutics (VBLX) Announces Second Quarter 2016 Financial Results And Provides Business Update 8/15/2016
China Pharma Holdings (CPHI.OB) Reports Second Quarter Financial Results 8/12/2016
Cipla (CIPLA) Announces Q1 FY17 Results Performance Reflects Continued Momentum In Key Markets And Improvement In Base EBITDA Margins 8/12/2016
Innocoll (INNL) To Report Second Quarter 2016 Financial Results And Host Webcast And Conference Call On August 17, 2016 8/12/2016
BioLineRx Reports Second Quarter 2016 Financial Results 8/11/2016
Bactiguard AB: Interim Report For Q2 2016 8/11/2016
Biotage AB (BIOTa.ST): Interim Report January - June 2016 8/11/2016
Elekta AB (SE:EKTAB)’s Annual Report For 2015/16 Available 8/11/2016
Medicure (MCU) Reports Second Quarter 2016 Financial Results 8/11/2016
Nuvo Pharmaceuticals Inc. Announces 2016 Second Quarter Results 8/11/2016
NeuroDerm (NDRM) To Host Second Quarter 2016 Financial Results Conference Call On August 25, 2016 8/11/2016
Origin Agritech Limited (SEED) Reports Unaudited Financial Results For The Third Quarter Fiscal 2016 8/11/2016
Concord Medical Services Holdings Limited (CCM) To Report First Half 2016 Financial Results On August 24, 2016 8/11/2016
VolitionRX Announces Second Quarter 2016 Financial Results and Business Update 8/11/2016
BioAmber Inc. Reports Second Quarter 2016 Financial Results 8/10/2016
Cardiome Pharma Corp. (COM.TO) Reports Second Quarter 2016 Financial Results 8/10/2016
Cipher Pharma (DND.TO) Reports Q2 2016 Results Highlighted By 32% Revenue Growth And $3.1 Million Cash From Operations 8/10/2016
Foamix Pharma (FOMX) Reports Second Quarter 2016 Financial Results And Provides Business Update 8/10/2016
Genmab A/S (GEN.CO) Announces Financial Results For The First Half Of 2016 And Improves 2016 Financial Guidance 8/10/2016
Jazz Pharma (JAZZ) Announces Second Quarter 2016 Financial Results 8/10/2016
Perrigo (PRGO) Reports Second Quarter 2016 Financial Results 8/10/2016
Sophiris Bio (SPHS) Reports Second Quarter 2016 Financial Results And Key Business Highlights 8/10/2016
Merus Labs International Inc.  (MSLI) To Present At U.S. Investor Conference And Announces Date Of Fiscal Q3 2016 Earnings Release 8/10/2016
Neovasc (NVC) Reports Second Quarter Results For 2016 8/10/2016
Acerus (TRLPF) Reports Second Quarter 2016 Results 8/9/2016
Endo International (ENDP) Reports Second Quarter 2016 Financial Results 8/9/2016
Flamel Technologies (FLML) Reports Second Quarter 2016 Results 8/9/2016
Moberg Pharma AB (Formerly known as Moberg Derma) Interim Report January – June 2016 8/9/2016



//-->